A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma

作者
Mengmeng Wang,Yuzhen Gao,Huijuan Feng,Elisa Warner,Mingrui An,Jian'an Jia,Shipeng Chen,Meng Fang,Jun Ji,Xing Gu,Chunfang Gao
出处
期刊:Cancer Medicine [Wiley]
卷期号:7 (3): 646-654 被引量:24
标识
DOI:10.1002/cam4.1341
摘要

Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are the most prevalent histologic types of primary liver cancer (PLC). Although ICC and HCC share similar risk factors and clinical manifestations, ICC usually bears poorer prognosis than HCC. Confidently discriminating ICC and HCC before surgery is beneficial to both treatment and prognosis. Given the lack of effective differential diagnosis biomarkers and methods, construction of models based on available clinicopathological characteristics is in need. Nomograms present a simple and efficient way to make a discrimination. A total of 2894 patients who underwent surgery for PLC were collected. Of these, 1614 patients formed the training cohort for nomogram construction, and thereafter, 1280 patients formed the validation cohort to confirm the model's performance. Histopathologically confirmed ICC was diagnosed in 401 (24.8%) and 296 (23.1%) patients in these two cohorts, respectively. A nomogram integrating six easily obtained variables (Gender, Hepatitis B surface antigen, Aspartate aminotransferase, Alpha-fetoprotein, Carcinoembryonic antigen, Carbohydrate antigen 19-9) is proposed in accordance with Akaike's Information Criterion (AIC). A score of 15 was determined as the cut-off value, and the corresponding discrimination efficacy was sufficient. Additionally, patients who scored higher than 15 suffered poorer prognosis than those with lower scores, regardless of the subtype of PLC. A nomogram for clinical discrimination of ICC and HCC has been established, where a higher score indicates ICC and poor prognosis. Further application of this nomogram in multicenter investigations may confirm the practicality of this tool for future clinical use.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学生艺苑完成签到 ,获得积分10
刚刚
Jasper的应助被M83采纳,获得10
刚刚
神外王001完成签到 ,获得积分10
刚刚
starry完成签到,获得积分10
2秒前
2秒前
2秒前
微雨若,,完成签到 ,获得积分10
2秒前
兔子爱吃胡萝卜完成签到,获得积分10
3秒前
哈哈哈完成签到 ,获得积分10
4秒前
tianqiyue1022完成签到,获得积分10
4秒前
WL完成签到,获得积分10
4秒前
hoichai完成签到,获得积分10
6秒前
sun完成签到,获得积分10
6秒前
shineshine完成签到 ,获得积分10
7秒前
8秒前
9秒前
俏皮的凝云完成签到 ,获得积分10
9秒前
寒冷曼文完成签到,获得积分10
9秒前
zhaozhao完成签到,获得积分10
10秒前
诤心完成签到 ,获得积分10
10秒前
沐泽完成签到 ,获得积分10
10秒前
55z完成签到,获得积分10
11秒前
Haosen完成签到,获得积分10
11秒前
朱哥永正完成签到,获得积分10
12秒前
舒化奶完成签到,获得积分10
13秒前
鹤立名堂完成签到 ,获得积分10
13秒前
侧耳倾听完成签到 ,获得积分10
14秒前
M83发布了新的文献求助10
14秒前
Daniel完成签到,获得积分10
14秒前
14秒前
领导范儿的应助被京刹而语采纳,获得10
15秒前
英俊的铭的应助被科研通管家采纳,获得10
16秒前
JamesPei的应助被科研通管家采纳,获得10
16秒前
wanci的应助被科研通管家采纳,获得10
16秒前
16秒前
Akim的应助被科研通管家采纳,获得10
16秒前
顾矜的应助被科研通管家采纳,获得10
16秒前
16秒前
17秒前
田様的应助被科研通管家采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185571
求助须知:如何正确求助?哪些是违规求助? 9574325
关于积分的说明 21835086
捐赠科研通 7783326
什么是DOI,文献DOI怎么找? 3434597
关于科研通互助平台的介绍 2558985
邀请新用户注册赠送积分活动 2481372